ARMO Biosciences Inc (ARMO)

NASDAQ
49.98
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    49.94/50.12
  • Day's Range:
    49.96 - 50.01

ARMO Overview

Prev. Close
49.97
Day's Range
49.96-50.01
Revenue
-
Open
49.98
52 wk Range
0-0
EPS
-2.13
Volume
0
Market Cap
1.52B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
475,780
P/E Ratio
-
Beta
-
1-Year Change
0%
Shares Outstanding
30,405,109
Next Earnings Date
-
What is your sentiment on ARMO Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

ARMO Biosciences Inc News

ARMO Biosciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellSellSellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy

ARMO Biosciences Inc Company Profile

ARMO Biosciences Inc Company Profile

Employees
31

ARMO BioSciences, Inc., an immuno-oncology company, develops a pipeline of products that activate the immune system of cancer patients to recognize and eradicate tumors. Its products include AM0010, a long acting form of interleukin 10 (IL-10) that is an immune growth factor that naturally occurs in the body of humans and functions as a stimulator of the immune system; AM0001, an anti-PD-1 monoclonal antibody; AM0003, an anti-LAG-3 checkpoint inhibitor; AM0015, a form of recombinant human interleukin-15 (IL-15); and AM0012, a form of recombinant human interleukin-12 (IL-12). ARMO BioSciences, Inc. was formerly known as Targenics, Inc. and changed its name to ARMO BioSciences, Inc. in December 2012. The company was incorporated in 2010 and is based in Redwood City, California. As of June 21, 2018, ARMO BioSciences, Inc. operates as a subsidiary of Eli Lilly and Company.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.